CIDARA THERAPEUTICS, INC. Stock Split Ratio
CIDARA THERAPEUTICS, INC. had Stock Split Ratio of 5.00% as of 2024-04-23, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-11-06
- 2024-04-23: Stockholders' Equity Note, Stock Split, Conversion Ratio 5.00%.
- 2015-04-02: Stockholders' Equity Note, Stock Split, Conversion Ratio 3.94%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2024-04-23 | 5.00% 10-Q · filed 2025-11-06 |
| 2015-04-02 | 3.94% 10-Q · filed 2016-05-12 |